Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
AIDS Research and Human Retroviruses|April 30, 2009
Human immunodeficiency virus type 1 gp 41 mutations in proviral DNA among antiretroviral treatment-naive individuals from IndiaSourav Sen, S P Tripathy, A K Sahni, et al.
Scientific Reports|May 4, 2026
Droplet size distribution characteristics of Bacillus thuringiensis and Beauveria bassiana bio-pesticide solutions for hydraulic nozzlesManish Kumar, C R Mehta, K N Agrawal, et al.
Journal of Clinical Microbiology|September 29, 2006
Development and evaluation of reverse transcription-loop-mediated isothermal amplification assay for rapid and real-time detection of Japanese encephalitis virusM M Parida, S R Santhosh, P K Dash, et al.
Emerging Infectious Diseases|September 30, 2022
Myocarditis Attributable to Monkeypox Virus Infection in 2 Patients, United States, 2022Guillermo Rodriguez-Nava, Peter Kadlecik, Thomas D Filardo, et al.
Biological Chemistry|July 13, 2019
Evolution, purification, and characterization of RC0497: a peptidoglycan amidase from the prototypical spotted fever species Rickettsia conoriiJignesh G Patel, Hema P Narra, Krishna Mohan Sepuru, et al.
Emerging Infectious Diseases|November 1, 2006
Japanese Encephalitis Outbreak, India, 2005Manmohan Parida, Paban K Dash, Nagesh K Tripathi, et al.
Medical Journal, Armed Forces India|April 11, 2015
Antimicrobial use and antimicrobial resistance in nosocomial pathogens at a tertiary care hospital in PuneVelu Nair, Dinesh Sharma, A K Sahni, et al.
The Indian Journal of Medical Research|October 26, 2017
Point prevalence & risk factor assessment for hospital-acquired infections in a tertiary care hospital in Pune, IndiaVelu Nair, A K Sahni, Dinesh Sharma, et al.
Blood Advances|February 24, 2026
MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphomaJia Ruan, David A Bond, Bijal Shah, et al.
Blood Advances|November 25, 2025
MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell LymphomaJia Ruan, David A Bond, Bijal D Shah, et al.
Pageof 18